These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27138923)

  • 1. Successful treatment of severe acute gastrointestinal graft-versus-host disease complicated by cytomegalovirus gastroenteritis with intra-arterial steroid infusion.
    Hirabayashi S; Kondo T; Oka T; Akamatsu Y; Hishizawa M; Shibata T; Kitano T; Takaori-Kondo A
    Ann Hematol; 2016 Aug; 95(8):1373-5. PubMed ID: 27138923
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra-arterial methylprednisolone for severe steroid refractory gastrointestinal graft-versus-host disease.
    Bhuller KS; Heran MK; Wu JK; Rassekh SR
    Pediatr Blood Cancer; 2014 Dec; 61(12):2321-3. PubMed ID: 25053422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of intra-arterial steroid administration in the management of steroid-refractory acute gastrointestinal graft-versus-host disease.
    Tfayli A; Selby G; Maqbool F; Bierbaum W; Hamadani M
    Am J Hematol; 2006 Dec; 81(12):959-62. PubMed ID: 16924649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation.
    Nishi T; Okazaki K; Fujii S; Uchida K; Uose S; Nakase H; Ohana M; Nishihara T; Chiba T
    Endoscopy; 2001 Nov; 33(11):985-7. PubMed ID: 11668409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment With α-1-Antitrypsin for Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease: A Report of 2 Cases.
    Gerner RR; Feistritzer C; Moschen AR; Kircher B; Moser P; Tilg H; Nachbaur D
    Transplantation; 2016 Dec; 100(12):e158-e159. PubMed ID: 27861298
    [No Abstract]   [Full Text] [Related]  

  • 6. Rash and GI symptoms on day +36.
    Weisdorf D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1405-6. PubMed ID: 17950925
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of intra-arterial steroid infusions in patients with steroid-resistant gastrointestinal acute graft-versus-host disease.
    Nishimoto M; Koh H; Hirose A; Nakamae M; Nakane T; Hayashi Y; Okamura H; Yoshimura T; Koh S; Nanno S; Nakashima Y; Takeshita T; Yamamoto A; Sakai Y; Nishida N; Matsuoka T; Miki Y; Hino M; Nakamae H
    Exp Hematol; 2015 Dec; 43(12):995-1000. PubMed ID: 26303639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
    Goussetis E; Paisiou A; Kitra V; Peristeri I; Vessalas G; Stefanaki K; Panayotou I; Giamaiou K; Kontou E; Kitzoni M; Dimopoulou MN; Karkelis S; Kafritsa Y; Rapsomaniki E; Papassotiriou I; Tsirigotis P; Roma E; Graphakos S
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1058-66. PubMed ID: 21073975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute graft-versus-host disease in a nonhematopoietic stem cell transplantation candidate treated with decitabine followed by granulocyte colony-stimulating factor-primed peripheral blood stem cells infusion: a special entity of the disease?
    Yuan L; Sun L; Yang L; Jing Y
    Transfusion; 2014 Jan; 54(1):190-3. PubMed ID: 23621702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung.
    Bolaños-Meade J; Ioffe O; Hey JC; Vogelsang GB; Akpek G
    Am J Hematol; 2005 Jun; 79(2):132-5. PubMed ID: 15929116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation.
    Sorà F; Chiusolo P; Metafuni E; Bellesi S; Giammarco S; Laurenti L; Ausoni G; Zini G; Bayer AJ; Mario B; Leone G; Sica S
    Leuk Res; 2011 Mar; 35(3):422-3. PubMed ID: 21093053
    [No Abstract]   [Full Text] [Related]  

  • 12. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
    Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
    Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide.
    Goldsmith SR; Slade M; DiPersio JF; Westervelt P; Lawrence SJ; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Dubberke ER; Trinkaus K; Romee R
    Haematologica; 2016 Nov; 101(11):e465-e468. PubMed ID: 27443287
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease.
    Jerkins JH; Hamadani M; Zook F; Epperla N; Shaw BE; Saber W; Rizzo JD; Pasquini M; Chhabra S; Drobyski WR; Hari PN; Shah NN
    Am J Hematol; 2017 Oct; 92(10):E610-E611. PubMed ID: 28699171
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral beclomethasone dipropionate as an initial treatment of gastrointestinal acute graft-versus-host disease after reduced-intensity cord blood transplantation.
    Miura Y; Narimatsu H; Kami M; Kusumi E; Matsumura T; Yuji K; Wake A; Miyakoshi S; Taniguchi S
    Bone Marrow Transplant; 2006 Oct; 38(8):577-9. PubMed ID: 16953206
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Hattori K; Doki N; Kurosawa S; Hino Y; Yamamoto K; Sakaguchi M; Harada K; Ikegawa S; Shingai N; Senoo Y; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
    Ann Hematol; 2017 Feb; 96(2):319-321. PubMed ID: 27766393
    [No Abstract]   [Full Text] [Related]  

  • 17. Intra-arterial steroid-injection therapy for steroid-refractory acute graft-versus-host disease with the evaluation of angiography.
    Nakai K; Tajima K; Tanigawa N; Matsumoto N; Zen K; Nomura S; Fujimoto M; Kishimoto Y; Amakawa R; Sawada S; Fukuhara S
    Bone Marrow Transplant; 2004 Jun; 33(12):1231-3. PubMed ID: 15094752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alemtuzumab as treatment of steroid-refractory acute graft-versus-host disease: results of a phase II study.
    Martínez C; Solano C; Ferrá C; Sampol A; Valcárcel D; Pérez-Simón JA;
    Biol Blood Marrow Transplant; 2009 May; 15(5):639-42. PubMed ID: 19361757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation.
    Massenkeil G; Rackwitz S; Genvresse I; Rosen O; Dörken B; Arnold R
    Bone Marrow Transplant; 2002 Dec; 30(12):899-903. PubMed ID: 12476283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
    Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K;
    Am J Hematol; 2016 May; 91(5):E284-92. PubMed ID: 26910296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.